Company Filing History:
Years Active: 2019-2021
Title: Taoufik Ouatas: Innovator in Pharmaceutical Compositions
Introduction
Taoufik Ouatas is a notable inventor based in Leiderdorp, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dosage forms of bendamustine. With a total of 2 patents to his name, Ouatas has demonstrated a commitment to advancing medical treatments.
Latest Patents
His latest patents include innovative pharmaceutical compositions designed for oral administration. The first patent focuses on solid dosage forms of bendamustine, which includes a composition comprising bendamustine or its pharmaceutically acceptable derivatives, along with a saccharide excipient. The specified weight ratio of the active ingredient to the excipient ranges from 1:1 to 5. The second patent details oral dosage forms of bendamustine that achieve a dissolution rate of at least 60% in 20 minutes, 70% in 40 minutes, and 80% in 60 minutes. This composition is intended for the treatment of various medical conditions, including chronic lymphocytic leukemia and breast cancer.
Career Highlights
Throughout his career, Ouatas has worked with reputable companies in the pharmaceutical industry, including Astellas Deutschland GmbH and Pharma & Schweiz GmbH. His work has contributed to the development of effective treatments for serious medical conditions.
Collaborations
Some of his notable coworkers include Ulrich Patzak and Jeffrey Colledge, who have collaborated with him on various projects in the pharmaceutical sector.
Conclusion
Taoufik Ouatas is a distinguished inventor whose work in pharmaceutical compositions has the potential to improve treatment options for patients. His innovative patents reflect his dedication to advancing medical science and enhancing patient care.